Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial
Titel:
Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial
Auteur:
Gooderham, Melinda J. Girolomoni, Giampiero Moore, Julian O. Silverberg, Jonathan I. Bissonnette, Robert Forman, Seth Peeva, Elena Biswas, Pinaki Valdez, Hernan Chan, Gary